Design Therapeutics, Inc. (DSGN) Return on equity 2024–2025
Design Therapeutics, Inc. (DSGN) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-32.8%FY2025 · since FY2024: -20.5% → -32.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -32.8% | -12.4 pp |
| FY2024 | -20.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice